343 related articles for article (PubMed ID: 26308769)
81. Recent survival trends in diffuse large B-cell lymphoma--Have we made any progress beyond rituximab?
Epperla N; Vaughn JL; Othus M; Hallack A; Costa LJ
Cancer Med; 2020 Aug; 9(15):5519-5525. PubMed ID: 32558356
[TBL] [Abstract][Full Text] [Related]
82. Multi-Database Description of Primary Splenic Diffuse Large B-Cell Lymphoma.
Byrd KP; Vontela NR; McCullar B; Martin MG
Anticancer Res; 2017 Dec; 37(12):6839-6843. PubMed ID: 29187463
[TBL] [Abstract][Full Text] [Related]
83. Clinical and treatment-related features determining the risk of late relapse in patients with diffuse large B-cell lymphoma.
Modvig L; Vase M; d'Amore F
Br J Haematol; 2017 Oct; 179(1):75-82. PubMed ID: 28653321
[TBL] [Abstract][Full Text] [Related]
84. [Primary testicular lymphoma].
Motyčková M; Vosáhlová V; Belada D; Šimkovič M; Žák P
Vnitr Lek; 2017; 63(6):415-422. PubMed ID: 28840738
[TBL] [Abstract][Full Text] [Related]
85. Unusually aggressive primary testicular diffuse large B-cell lymphoma initially presenting as systemic disseminating metastases in older adult men: a case report.
Liu KT; Chang YC; Lin YC; Chang JL
Ann Med Surg (Lond); 2023 Aug; 85(8):4106-4111. PubMed ID: 37554871
[TBL] [Abstract][Full Text] [Related]
86. Genomic landscape and distinct molecular subtypes of primary testicular lymphoma.
Zhang W; Yang P; Yang Y; Liu S; Xu Y; Wu C; Wang J; Liu C; Liu H; Li S; Huang W; Jing H
J Transl Med; 2024 May; 22(1):414. PubMed ID: 38693538
[TBL] [Abstract][Full Text] [Related]
87. Testicular Relapse of Primary Diffuse Large B-cell Lymphoma of the Central Nervous System - a Rare Occurrence.
Ollila TA; Kishkovich TP; Olszewski AJ; Patel NR; Jackson C; Roussel B; Niroula R; Treaba DO
R I Med J (2013); 2023 Mar; 106(2):8-12. PubMed ID: 36848533
[TBL] [Abstract][Full Text] [Related]
88. Sinonasal B-cell lymphomas: A nationwide cohort study, with an emphasis on the prognosis and the recurrence pattern of primary diffuse large B-cell lymphoma.
Eriksen PRG; Clasen-Linde E; Nully Brown P; Haunstrup L; Christoffersen M; Asdahl P; Thomsen TM; Harwood CD; Heegaard S; Buchwald CV
Hematol Oncol; 2022 Apr; 40(2):160-171. PubMed ID: 35104916
[TBL] [Abstract][Full Text] [Related]
89. Primary Testicular Lymphoma: Single Center Experience.
Shah S; Sreenivasan S; Kancharla P; Khan C; Samhouri Y
Cancer Diagn Progn; 2023; 3(2):139-144. PubMed ID: 36875297
[TBL] [Abstract][Full Text] [Related]
90. Primary extra-nodal diffuse large B-cell lymphoma: A prognostic analysis of 141 patients.
Shen H; Wei Z; Zhou D; Zhang Y; Han X; Wang W; Zhang L; Yang C; Feng J
Oncol Lett; 2018 Aug; 16(2):1602-1614. PubMed ID: 30008843
[TBL] [Abstract][Full Text] [Related]
91. Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era.
Khurana A; Novo M; Nowakowski GS; Ristow KM; Spinner RJ; Hunt CH; King RL; Lachance DH; Habermann TM; Micallef IN; Johnston PB
Blood Adv; 2021 Mar; 5(5):1379-1387. PubMed ID: 33661298
[TBL] [Abstract][Full Text] [Related]
92. Role of radiation therapy in primary tonsil large B cell lymphoma: a SEER-based analysis.
Jia J; Chen W
Radiat Oncol; 2021 Oct; 16(1):193. PubMed ID: 34600539
[TBL] [Abstract][Full Text] [Related]
93. [Clinical manifestation and treatment of extranodal diffuse large B-cell lymphoma].
Tomita N
Rinsho Ketsueki; 2016; 57(10):1991-1999. PubMed ID: 27725597
[TBL] [Abstract][Full Text] [Related]
94. The survival and prognostic factors of primary testicular lymphoma: two-decade single-center experience.
Ma RZ; Tian L; Tao LY; He HY; Li M; Lu M; Ma LL; Jiang H; Lu J
Asian J Androl; 2018; 20(6):615-620. PubMed ID: 30246707
[TBL] [Abstract][Full Text] [Related]
95. Primary breast diffuse large B-cell lymphoma in the era of rituximab.
Zhang N; Cao C; Zhu Y; Liu P; Liu L; Lu K; Luo J; Zhou N
Onco Targets Ther; 2016; 9():6093-6097. PubMed ID: 27785056
[TBL] [Abstract][Full Text] [Related]
96. Deregulated over expression of FOXP1 protein in diffuse large B-cell lymphoma does not occur as a result of gene rearrangement.
Barrans SL; Fenton JA; Ventura R; Smith A; Banham AH; Jack AS
Haematologica; 2007 Jun; 92(6):863-4. PubMed ID: 17550867
[TBL] [Abstract][Full Text] [Related]
97. The Mutation of
Guo D; Hong L; Ji H; Jiang Y; Lu L; Wang X; Huang H
J Inflamm Res; 2022; 15():1757-1769. PubMed ID: 35300216
[TBL] [Abstract][Full Text] [Related]
98. Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China.
Shi Y; Han Y; Yang J; Liu P; He X; Zhang C; Zhou S; Zhou L; Qin Y; Song Y; Liu Y; Wang S; Jin J; Gui L; Sun Y
Chin J Cancer Res; 2019 Feb; 31(1):152-161. PubMed ID: 30996573
[TBL] [Abstract][Full Text] [Related]
99. The significance of single nucleotide polymorphism rs2070770 in CD20 gene in Chinese patients with diffuse large B-cell lymphoma.
Zhang LN; Wang L; Fang C; Zou ZJ; Fan L; Zhang R; Young KH; Li JY; Xu W
Leuk Lymphoma; 2015 Mar; 56(3):676-81. PubMed ID: 24898664
[TBL] [Abstract][Full Text] [Related]
100. Treatment of primary testicular diffuse large B cell lymphoma without prophylactic intrathecal chemotherapy: a single center experience.
Kim J; Yoon DH; Park I; Kim S; Park JS; Lee SW; Huh J; Park CS; Suh C
Blood Res; 2014 Sep; 49(3):170-6. PubMed ID: 25325036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
